Abstract
Many insect species including mosquitoes transmit a wide range of pathogens to animals and humans, causing a variety of vector-borne diseases (VBDs). For humans, VBDs currently account for more than 17% of all infectious diseases causing more than 700,000 deaths annually. Thus, insect disease vectors (IDVs) pose a significant threat to global public and animal health and have substantial socioeconomic impacts. Although effective control of IDVs is crucial, it is also challenging.
Insects rely on their olfactory system to sense volatile chemicals that regulate crucial behaviors, including social interactions, mate and oviposition site selection and food source location. An effective and safe control method for their control involves the use of long lasting, environmentally friendly repellents and anosmia-inducing agents. These agents interfere with the olfactory capacity of blood feeding insects and reduce the frequency of their biting host organisms and transmitting pathogens to them.
Insect odor receptors (ORs) are heteromeric ligand-gated cation channels expressed in olfactory sensory neurons. Each receptor is composed of one of many variable subunits, ORx, which confer specificity to odor recognition, and an obligatory receptor subunit, ORco, which is necessary for channel formation and signal transduction. ORco is highly conserved amongst different insect orders, spanning many hundreds of millions of years of evolution. In the absence of a co-expressed ORx subunit, ORco can form, at least ex vivo, homotetrameric cation channels whose function may be activated or suppressed by synthetic ORco agonists and antagonists, respectively. Moreover, ORco antagonists have broad inhibitory activities on the majority of heteromeric ORs of a variety of insects. Given such considerations, the identification of volatile ORco antagonists that may interrupt insect–host recognition and thus reduce and prevent the spread of VBDs, is crucial.
This presentation will describe the recent development of an integrated screening platform consisting of an ex vivo guided, ligand-based in silico screening element and ex vivo and in vivo functional validation assays. This platform is employed on collections of natural volatile metabolites in conjunction with the odorant coreceptor of the African blood feeding mosquito Anopheles gambiae, AgamORco, in order to achieve an accelerated pace of discovery of ORco antagonists of natural origin. The employment of this screening platform resulted in the identification of several AgamORco antagonists that inhibit the function of most mosquito odor receptors, cause anosmia to multiple mosquito species and block their biting behaviors, thereby their capacity to transmit IVDs to animal and human hosts. Ongoing molecular modeling and molecular dynamics (MD) studies on 3D-models of AgamORco, which aim to identify antagonist-binding sites and -binding modes, as well as relevant functional correlations, will also be presented and discussed.
Biography
Dr. Kostas Iatrou, formerly Professor of Biochemistry and Molecular Biology at the Faculty of Medicine, University of Calgary, Canada (1981-2001; Adjunct Professor 2001-today) and Director of the Institute of Biology at the National Centre for Scientific Research “Demokritos” in Athens, Greece (1988-2003), is the Head of the Institute’s “Insect Molecular Genetics and Biotechnology” Group. His expertise is in insect developmental genetics, molecular biology and biotechnology.